Stock Research for INCY

INCY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

INCY Stock Chart & Research Data

The INCY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the INCY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


INCY Due diligence Resources & Stock Charts

The INCY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View INCY Detailed Price Forecast - CNN Money CNN View INCY Detailed Summary - Google Finance
Yahoo View INCY Detailed Summary - Yahoo! Finance Zacks View INCY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View INCY Trends & Analysis - Trade-Ideas Barrons View INCY Major Holders - Barrons
NASDAQ View INCY Call Transcripts - NASDAQ Seeking View INCY Breaking News & Analysis - Seeking Alpha
Spotlight View INCY Annual Report - CompanySpotlight.com OTC Report View INCY OTC Short Report - OTCShortReport.com
TradeKing View INCY Fundamentals - TradeKing Charts View INCY SEC Filings - Bar Chart
WSJ View Historical Prices for INCY - The WSJ Morningstar View Performance/Total Return for INCY - Morningstar
MarketWatch View the Analyst Estimates for INCY - MarketWatch CNBC View the Earnings History for INCY - CNBC
StockMarketWatch View the INCY Earnings - StockMarketWatch MacroAxis View INCY Buy or Sell Recommendations - MacroAxis
Bullish View the INCY Bullish Patterns - American Bulls Short Pains View INCY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View INCY Stock Mentions - StockTwits PennyStocks View INCY Stock Mentions - PennyStockTweets
Twitter View INCY Stock Mentions - Twitter Invest Hub View INCY Investment Forum News - Investor Hub
Yahoo View INCY Stock Mentions - Yahoo! Message Board Seeking Alpha View INCY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for INCY - SECform4.com Insider Cow View Insider Transactions for INCY - Insider Cow
CNBC View INCY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for INCY - OTC Markets
Yahoo View Insider Transactions for INCY - Yahoo! Finance NASDAQ View Institutional Holdings for INCY - NASDAQ


Stock Charts

FinViz View INCY Stock Insight & Charts - FinViz.com StockCharts View INCY Investment Charts - StockCharts.com
BarChart View INCY Stock Overview & Charts - BarChart Trading View View INCY User Generated Charts - Trading View




Latest Financial News for INCY


Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
Posted on Wednesday April 24, 2024

Allogene Therapeutics (ALLO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.


Incyte (INCY) Earnings Expected to Grow: Should You Buy?
Posted on Tuesday April 23, 2024

Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.


Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Posted on Tuesday April 23, 2024

Incyte's (INCY) first-quarter 2024 revenues are likely to have been driven by the U.S. sales and royalties from Novartis on ex-U.S. sales of its lead drug, Jakafi.


Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Posted on Tuesday April 23, 2024

WILMINGTON, Del. & SAN DIEGO, April 23, 2024--Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists


Stock Market & Investing Books

Enter a stock symbol to view the stock details.